Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2-Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan.

ABSTRACT:

SUBMITTER: Amano M 

PROVIDER: S-EPMC9129163 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature